University of Melbourne
Researchers reported prospective randomized trial data showing non-inferiority of adjuvant treatment guided by minimal residual disease testing.
The researchers at the Royal College of Surgeons Ireland recently received €1.3 million from Wellcome Trust to support the development of the blood-based test.
COVID-19 Testing Could Get Boost From Alternative Sample Types
Replacing nasopharyngeal swabs with saliva samples or nasal swabs could increase throughput and convenience, as well as relieve reagent and equipment shortages.
University of Melbourne, Illumina Launch A$6M Initiative for Cancers of Unmet Need
The project, the first under a partnership between the university and Illumina announced last year, will apply whole-genome sequencing to challenging cancers types.
Cascade Testing for Dilated Cardiomyopathy Likely to Be Cost Effective, Analysis Finds
An Australian team developed a decision model for testing asymptomatic relatives of patients with dilated cardiomyopathy to assess the cost effectiveness of testing.